Teva Womens Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TEVA WOMENS, and what generic and branded alternatives to TEVA WOMENS drugs are available?
TEVA WOMENS has eight approved drugs.
Drugs and US Patents for Teva Womens
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Womens | VIVACTIL | protriptyline hydrochloride | TABLET;ORAL | 016012-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-002 | Jul 31, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Teva Womens | ADDERALL 7.5 | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | TABLET;ORAL | 011522-011 | Aug 31, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Teva Womens
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Womens | ADDERALL 20 | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | TABLET;ORAL | 011522-008 | Feb 13, 1996 | 6,384,020*PED | ⤷ Sign Up |
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-002 | Jul 31, 1992 | 4,258,062*PED | ⤷ Sign Up |
Teva Womens | ADDERALL 10 | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | TABLET;ORAL | 011522-007 | Feb 13, 1996 | 6,384,020*PED | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TEVA WOMENS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 5 mg, 10 mg, 20 mg, 30 mg | ➤ Subscribe | 2009-11-18 |
Similar Applicant Names
Here is a list of applicants with similar names.